Form D — Coeptis Therapeutics Holdings, Inc.
0001683168-25-005718 · filed Aug 7, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $5,000,000
- Reported amount sold
- $4,000,000
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Coeptis Therapeutics Holdings, Inc.
- CIK
- 1759186
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 105 BRADFORD ROAD
WEXFORD, Pennsylvania 15090 - Phone
- 724-934-6467
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Mehalick · Executive OfficerWexford, Pennsylvania Find on LinkedIn ↗
-
Daniel Yerace · DirectorWexford, Pennsylvania Find on LinkedIn ↗
-
Brian Cogley · Executive OfficerWexford, Pennsylvania Find on LinkedIn ↗
-
Christopher Calise · DirectorWexford, Pennsylvania Find on LinkedIn ↗
-
Christopher Cochran · DirectorWexford, Pennsylvania Find on LinkedIn ↗
-
Tara Maria DeSilva · DirectorWexford, Pennsylvania Find on LinkedIn ↗
-
Philippe Deschamps · DirectorWexford, Pennsylvania Find on LinkedIn ↗
-
Gene Salkind · DirectorWexford, Pennsylvania Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗